跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
盐酸度洛西汀肠溶胶囊 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Duloxetine Hydrochloride Enteric Capsules
Approved
化学药品
Duloxetine Hydrochloride Enteric Capsules
HETERO LABS LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Sep 19, 2024
Approval ID
8dEvIK0FDjB
Company
HETERO LABS LIMITED
Type
化学药品
Approval Details
Approval Id
8dEvIK0FDjB
Approval Number
国药准字HJ20240093
Generic Name
盐酸度洛西汀肠溶胶囊
Generic Name En
Duloxetine Hydrochloride Enteric Capsules
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
30mg(按C₁₈H₁₉NOS计)
Reg Date
2024-09-19
Expired Date
2029-09-18
Company Name
HETERO LABS LIMITED
Production Company Name
HETERO LABS LIMITED
Company Detail Path
/organization/hetero-labs-limited
Production Company Detail Path
/organization/hetero-labs-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Sep 19, 2024
Approval ID
8dEvIK0FDjB
Type
化学药品
Back to NMPA Approvals